Alkermes
Price & Volume
Stats
See moreOpen | $46.51 |
Previous Close | $45.69 |
Day Range | $44.58-$46.51 |
52W Range | $27-$55.67 |
Market Cap | $7.5B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $1.6B |
Revenue Growth (YoY) | 27% |
Gross Profit (12 Mos) | $1.4B |
Diluted EPS | $0.38 |
News
See moreYahoo Finance • 2 days ago
Alkermes: Q3 Earnings Snapshot
Yahoo Finance • 2 days ago
Alkermes plc Reports Third Quarter 2026 Financial Results
Yahoo Finance • 6 days ago
Alkermes Expands ALKS 7290 Development Program With Initiation of Phase 2 Study for the Adjunctive Treatment of Major Depressive Disorder (MDD)
Yahoo Finance • 8 days ago
Linde (LIN) vs. APD and DOW: Can Long-Term Contracts and Pricing Power Unlock More Upside?
About
CEO | Mr. Blair C. Jackson |
CFO | Mr. Joshua Reed M.B.A. |
Address | Connaught House, Dublin, Ireland, D04 C5Y6 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 2,050 |